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Enhanced Apoptosis and Senescence
of Bone-Marrow-Derived Mesenchymal Stem Cells
in Patients with Systemic Lupus Erythematosus
Xia Li,1,* Lei Liu,1,* Defang Meng,1,* Dandan Wang,1 Jiyun Zhang,1 Dongyan Shi,1
Huiqing Liu,1 Huji Xu,2 Liwei Lu,3 and Lingyun Sun1
Previous studies indicated that bone marrow mesenchymal stem cells (BMSCs) from patients with systemic
lupus erythematosus (SLE) exhibited impaired capacities of proliferation, differentiation, secretion of cytokines,
and immune modulation. In this study, we aimed to investigate whether apoptosis and senescence of SLE
BMSCs were dysregulated. We found that there were increased frequencies of apoptotic and aging SLE BMSCs
in comparison with those of normal controls. Notably, levels of Bcl-2 expression in SLE BMSCs were markedly
decreased both at mRNA and protein levels. When BMSCs were induced to apoptosis by tumor necrosis factor-a
(TNF-a) stimulation in vitro, the Bax and caspase 8 expression in SLE BMSCs was significantly increased at
mRNA levels. The activity of caspase 8 was also enhanced in SLE BMSCs. More cytochrome-C-positive pellets in
the cytosolic fraction of BMSCs were detected in SLE patients than in normal controls. The expression of Fas and
tumor necrosis factor-a receptor 1 in SLE BMSCs was significantly upregulated compared with normal controls,
and the serum levels of FasL and TNF-a were also elevated. Moreover, intracellular reactive oxygen species
levels of SLE BMSCs were higher than those of normal controls, with the activation of PI3K/AKT/FoxO3
signaling pathway. Taken together, our results demonstrate increased apoptosis and senescence in SLE BMSCs,
which may be associated with the pathogenesis of SLE.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmuneinflammatory disease characterized by multiorgan in-
volvements and a wide array of clinical manifestations. There
is increasing evidence that dysregulation of stem cells is in-
volved in the pathogenesis of SLE [1]. Previous studies found
that hematopoietic stem cells (HSCs) from SLE patients were
prone to apoptosis with defects in their function [2]. HSC
transplantation (HSCT) has shown to be as a powerful strat-
egy in the treatment of refractory SLE patients [3], which
suggests that bone marrow microenvironment may be
somewhat functionally deficient. Bone marrow mesenchymal
stem cells (BMSCs), characterized by their self-renewal and
pluripotent differentiation capability, are nonhematopoietic
cells located in the bone marrow microenvironment [4–6].
Therefore, we presume that a disorder of the bone marrow
microenvironment may lead to the abnormality of SLE
BMSCs. Our data and others’ data revealed that SLE BMSCs
grew more slowly with early signs of senescence, and ex-
hibited some abnormalities of the cytoskeleton and ultra-
structure [7–9]. In addition, allogenic MSC transplantation
(MSCT) appears to be a feasible and safe therapy strategy in
lupus-prone mice [10]. A follow-up investigation of 15 per-
sistently active SLE patients receiving MSCT has further
demonstratedMSCT efficacy in treating refractory and severe
SLE patients [11]. In this study, we aimed to determine
whether or not SLE BMSCs exhibited abnormalities of se-
nescence or apoptosis, which might contribute to the disease
pathogenesis.
It has become evident that reactive oxygen species (ROS)
are involved in proliferation, migration, and differentiation
of BMSCs [12]. However, intracellular ROS accumulation
appears to be the main cause of the senescence of human
BMSCs [13,14], and also related to the apoptosis of BMSCs
[15]. Many studies have shown that FoxO3 blocked by
phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is
one of the major factors to prevent ROS accumulation by
activating genes encoding the oxidative-stress-response
proteins. Moreover, previous researches have elucidated that
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upregulation of FoxO3 during chondrogenesis was likely to
be associated with BMSC survival [16].
Apoptosis is also induced by other stimuli that activate 2
major cell death signaling pathways, that is, the intrinsic and
extrinsic pathways [17, 18]. The intrinsic pathway (or mito-
chondrial pathway) involves the translocation of Bax from the
cytosol to the mitochondria, which results in the release of
proteins, such as cytochrome C, from the intermembrane space
of mitochondria. Alterations of mitochondrial membrane
proteins, such as Bcl-2, are also involved in the intrinsic
pathway. In the death receptor (DR) or extrinsic pathway,
specific cell surface receptors, including Fas and the tumor
necrosis factor-a receptor 1 (TNFR1), trigger a cascade of cas-
pase activation. Among them, caspase 8 is a common apop-
totic mediator in a variety of mammalian cell types [19].
In this study, we examined the activity of senescence-
associated b-galactosidase (SAb-gal) and the frequency of
apoptotic BMSCs. In addition, those proteins related to ap-
optotic regulation, including Bcl-2, Fas, TNFR1, cytochrome
C, and caspase 8, were investigated. We also detected in-
tracellular ROS levels and related regulatory PI3K/AKT/
FoxO3 signaling pathway.
Materials and Methods
Recruitment of SLE patients
Ten female SLE patients, aged 19 to 51 years (mean
34.0–8.7 years), were enrolled in the study. All fulfilled the
diagnostic criteria of SLE proposed by the American College of
Rheumatology [20]. Ten female healthy donors served as
normal controls, aged 30 to 57 years (mean 39.0–7.0 years).
The study was approved by the Ethics Committee at The
Drum Tower Hospital of Nanjing University Medical School
and registered at ClinicalTrials.gov (Identifier: NCT00698191).
Informed consent was obtained from each patient and healthy
donor.
Isolation, cell culture, and identification of BMSCs
BMSCs were isolated and expanded from iliac crest bone
marrow of all the SLE patients and normal controls. Ten
microliters of heparinized bone marrow were mixed with an
equal volume of phosphate-buffered saline (PBS). Then, the
resuspended cells were layered over 1.077g/mL Ficoll (TBD)
solution and centrifuged at 600 g for 30min at room tem-
perature. The mononuclear cells were collected at the inter-
face and resuspended in low-glucose Dulbecco’s modified
Eagle’s medium (L-DMEM) (Gibco) supplemented with 10%
heat inactivated fetal bovine serum (Invitrogen) and 1%
antibiotic-antimycotic solution. Then, the cells were plated at
a density of 2· 107 cells per 25 cm2 dish and cultured at 37C
in a 5% CO2 incubator, and the medium was changed after
48 h and then every 3 days. When the BMSCs were confluent,
the cells were recovered by the addition of 0.25% trypsin–
ethylenediaminetetraacetic acid (Gibco); they were then re-
plated at a density of 1· 106 cells per 25 cm2 dish. Passage 4
BMSCs were harvested. Flow cytometric (FCM) analysis
confirmed that the cells expressed CD105, CD44, and CD29
> 95%, in parallel with CD14, CD34, CD45, and HLA-DR
expression of < 5% (Supplementary Fig. S1; Supplementary
Data are available online at www.liebertonline.com/scd). In
addition, adipogenic and osteogenic gene expression of
MSCs from SLE and normal controls was shown in Sup-
plementary Fig. S2. The growth curves of MSCs from SLE
and normal controls showed that the population doubling
time of SLE MSCs was slower than that of normal controls
(Supplementary Fig. S3).
FCM analysis for cell apoptosis
The Annexin V-FITC/PI Apoptosis Detection Kit (Becton
Dickinson) was employed to evaluate the apoptosis of passage
4 BMSCs from 8 SLE patients and 8 normal controls by using
FCM analysis. After being washed with ice-cold PBS, 1·105
cells were resuspended in 100mL of binding buffer. Five mi-
croliters of Annexin V and 5mL of propidium iodide (PI) were
added to the cells. After incubation for 15min (25C) in the
dark, 400mL of 1·binding buffer was added to each tube and
FCM analysis was performed immediately. Data acquisition
and analysis were assayed by BD LSRII analyzer (Becton
Dickinson) using ‘‘CellQuest’’ software. Annexin V (+ ) and PI
(- )/PI (+ ) cells were considered as apoptotic cells.
Senescence-associated b-galactosidase assay
BMSCs from 3 SLE patients and 3 normal controls were
passaged into 6-well culture plates at a density of 5· 104 cells
per well. After 72 h, senescence-associated SAb-gal was as-
sayed at pH 6.0 as described in assay instructions (CHEMI-
CON). Briefly, cells were washed twice with PBS, and fixed
into the wells using 1mL 1·fixing solution per well, and
then incubated at room temperature for 15min. Following
washing with PBS, cells were then incubated in freshly pre-
pared staining SAb-gal detection solution at 37C without
CO2 and protected from the light for about 18 h. The per-
centage of senescent cells was obtained by counting the
number of blue-stained cells and the total cells per field
under a light microscope.
FCM analysis for Bcl-2 and caspase-8 activities
FCM analysis was performed on passage 4 BMSCs from 8
SLE patients and 8 normal controls in this experiment ac-
cording to manufacturer’s protocol. Phycoerythrin-labeled
anti-human B cell leukemia/lymphoma 2 (Bcl-2) (Bioscience)
was used. The activity of caspase-8 was measured by
GaspGLOW fluorescein active caspase 8 staining kit (Biovi-
sion). BMSCs were incubated with fluorescein isothiocyanate
(FITC)-conjugated z-DEVD-fmk and IFTD-fmk.
Enzyme-linked immunosorbent assay for serum
levels of FasL and TNF-a
Serum samples were stored at - 20C until assayed. Ser-
um levels of FasL and TNF-a were determined by a sand-
wich solid-phase enzyme-linked immunosorbent assay
(Biovision) according to manufacturer’s protocol. The optical
density was measured in a detector (Bio-Rad) at 450 nm
wavelength.
Detection of intracellular ROS levels
Intracellular ROS levels from 5 SLE patients and 5 normal
controls were measured by means of an oxidation-sensitive
fluorescent probe (DCFH-DA). About 1 · 106 cells of MSCs
were collected and washed twice in PBS. They were then
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incubated with 10 mmol/L DCFH-DA at 37C for 20min
according to the manufacturer’s instructions (Beyotiome).
DCFH-DA was deacetylated intracellularly by nonspecific
esterase, which was further oxidized by ROS to the fluores-
cent compound 2,7-dichlorofluorescein (DCF). DCF fluores-
cence was detected by FCM analysis when exposed to an
excitation wavelength of 488 nm and emission at 535 nm.
RNA isolation and real-time polymerase
chain reaction
BMSCs from 10 SLE patients and 10 normal controls in the
presence or absence of TNF-a (100 ng/L) were placed in
TRIzol (Invitrogen) and total cellular RNA was extracted.
cDNA was synthesized using PrimerScript RT reagent Kit
(TaKaRa). Glyceraldehyde phosphate dehydrogenase
(GAPDH) was regarded as the house-keeping gene. All
primers were designed by using the Primer Express 2.0
Software (Applied Biosystems), synthesized by Takara Corp.
(Shanghai), and the sequences are shown in Table 1.
Real-time polymerase chain reaction (PCR) was carried
out in triplicate for each sample in 96-well plates using SYBR
Green I Dye in the Applied Biosystems 7500 real-time PCR
system (Applied Biosystems). Reactions were performed in a
20 mL reaction volume and cycling times and temperatures
were as follows: initial denaturation was carried out for 10 s
at 95C, followed by 45 cycles of denaturation at 95C for 5 s
and combined primer annealing/extension at 60C for 34 s.
Data were analyzed using SDS software, version 2.0 (Ap-
plied Biosystems). The DCT value was determined by sub-
tracting the GAPDH CT value from the target gene CT value.
Relative gene expression was calculated as 2 - (DCT each
- DCT mean), where DCT each =DCT value of each sample
and DCT mean=mean DCT values of normal controls.
Protein extraction and western blot analysis
BMSCs from 3 SLE patients and 3 normal controls were
harvested and centrifuged at 500 g for 10min at 4C after 6
days of culture. The pellets were resuspended in lysis buffer
for 30min, and then centrifuged at 14,000 g for 10min at 4C.
The supernatants were collected and quantified with Brad-
ford Protein assay.
To analyze protein levels, supernatants with equal
amounts of proteins were mixed with 5· sodium dodecyl
sulfate (SDS) sample buffer and boiled for 5min, and then
separated through 8% to 15% SDS–polyacrylamide gel elec-
trophoresis gels. The proteins were transferred to nitrocel-
lulose membranes by a semidry blotting system after
electrophoresis. The membranes were incubated with 5%
skim milk to block nonspecific binding at 4C followed with
primary antibodies, including antibodies against Fas,
TNFR1, caspase 8 (Biovision), p-FoxO3, FoxO3, p-AKT, and
AKT (Cell Signaling Technology). Anti-GAPDH antibody
(Sigma) was used as a loading control. After being washed
in Tris-buffered saline with Tween (TBST), the membranes
were incubated for 2 h with horseradish-peroxidase-
conjugated secondary antibody. Bands were visualized by
enhanced chemoluminescence and exposed to radiography
film after the membranes were washed with TBST.
Immunocytochemistry
Cells from 4 SLE patients and 5 normal controls were
passaged into 6-well culture plates at a density of 5 · 104 cells
per well. After 72 h, cells were fixed with 2% paraformal-
dehyde buffer containing 78mmol/L L-lysine and 10mmol/
L NaIO4 for 20min at room temperature and washed with
PBS for 3 times. Cells were then incubated in 0.3% Triton X-
100 for 5min, blocked in 10% goat serum albumin for 20min,
rinsed, and incubated for 60min at room temperature with
primary antibody against cytochrome C (Millipore). Cells
were subsequently rinsed with PBS, incubated with hema-
toxylin-conjugated secondary antibody for 45min at room
temperature, and examined by light microscopy (Olympus).
Statistical analysis
Data analysis was performed using SPSS16.0. Categorical
data were expressed as counts and continuous data as
mean– standard deviation (SD). Differences between 2
groups were assessed by 2-tailed Student’s t-test for para-
metric variables and Mann–Whitney rank test for nonpara-
metric variables. The P-values < 0.05 were considered as
statistically significant in this study.
Results
Increased apoptosis and senescence in BMSCs
from SLE patients
BMSCs were successfully isolated and culture-expanded
from all SLE patients and normal controls. We sought to assess
Table 1. Specific Oligonucleotide Primers for Marker Genes to Detect the Apoptosis
and Senescence in Human Mesenchymal Stem Cells at mRNA Levels
Gene Primer Forward
Bcl-2 5¢-TCAGCATGGCTCAAAGTGCAG-3¢ 5¢-GAAACAGATGTCCCTACCAACCAGA-3¢
Caspase 8 5¢-CCAAATGCAAACTGGATGATGAC-3¢ 5¢-CTCTTGTTGATTTGGGCACAGAC-3¢
Bcl-w 5¢-GCCACTTGGTCTTGTTGTGAGTATG-3¢ 5¢-GGCTCTGCCAAGCAGTTTGAA-3¢
Bax 5¢-GCGAGTGTCTCAAGCGCATC-3¢ 5¢-CCAGTTGAAGTTGCCGTCAGAA-3¢
TNFR 5¢-AACATTTCTTTC-CGACAT-3¢ 5¢-GCTCCTGGCTCTGCTGAT-3¢
Fas 5¢-CCAAATGCAGAAGATGATTGTGTG-3¢ 5¢-TGCCACTGTTTCAGGATTTAAGGTTG-3¢
PI3K 5¢-ACT TTGTGACCTTCGGCTTT-3¢ 5¢-TACATTCCTGATCTTCCTCG-3¢
KRas 5-AAACTTGTGGTAGTTGGAGCTGGTG-3 5-GGTCCCTCATTGCACTGTACTCCT-3
Nras 5-GTGCCTGGCCAGCTGTCATA-3 5-ATCCGGCATGGTAGCCTTCA-3
FoxO3 5-TTGAAGCGGATGCCCAAATAA-3 5-GCCGCACACGTATTTCTGGA-3
GAPDH 5¢-AGAAGGCTGGGGCTCATTTG-3¢ 5¢-AGGGGCCATCCACAGTCTTC-3¢
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FIG. 1. Determination of the apoptosis and
senescence of BMSCs from SLE patients and
normal controls. BMSCs at passage 4 were
isolated and harvested from SLE patients
and normal controls, and analyzed by An-
nexin V-FITC/PI staining. Annexin-V-posi-
tive cells were 3.7% – 3.5% in normal controls
and 26.2%– 13.0% in SLE patients (P < 0.05,
n = 6) (A). To identify senescent cells, BMSCs
at passage 4 were stained for SAb-gal, and
observed under a light microscope (magni-
fication, 40· ). There were 12.4% – 0.7% and
31.8% – 9.0% SAb-gal-positive cells, respec-
tively, for normal controls and SLE patients
(P < 0.05, n= 4) (B). (* means P < 0.05 com-
pared with NC). BMSCs, bone marrow
mesenchymal stem cells; SLE, systemic lupus
erythematosus; SAb-gal, senescence-associ-
ated b-galactosidase; NC, normal controls.
FIG. 2. The analysis of apoptosis-related mitochondrial pathway in SLE BMSCs. Genes were evaluated by real-time PCR
from 10 SLE patients and 10 normal controls, and data were shown as the mean ratio– SD of transcript levels over GAPDH.
The antiapoptotic factor Bcl-2 mRNA expression was significantly decreased in SLE BMSCs compared with those in normal
controls with or without TNF-a (P < 0.05) (A). The mRNA expression of Bcl-w and Bax was failed to detect any significant
differences without TNF-a stimulation. While the mRNA expression of Bax was significantly increased in SLE BMSCs treated
with TNF-a for 48 h (B, C). The percentage of Bcl-2-positive SLE BMSCs decreased by FCM analysis (D). Immunostaining was
performed to investigate cytochrome C diverse in the cytosolic fraction between SLE patients (n= 4) and normal controls
(n = 5). The results showed more masculine pellet in the cytosolic fraction in SLE patients than in normal controls, which was
determined by light microscopy (magnification, · 100) (E). (* means P < 0.05 compared with NC). PCR, polymerase chain
reaction; GAPDH, glyceraldehyde phosphate dehydrogenase; TNF-a, tumor necrosis factor-a; FCM, flow cytometric.
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apoptotic cells using FCM analysis by Annexin V-FITC/PI
staining at the fourth passage. Figure 1A showed a significant
increase in Annexin-V-positive cells among BMSCs in SLE
patients (26.2%– 13.0%) compared with normal controls
(3.7%– 3.5%) (P<0.05, n= 6). While we did not find a signifi-
cant increase in apoptosis in P5 BMSCs in comparison with P4
BMSCs no matter SLE patients or normal controls (Supple-
mentary Fig. S4).
To characterize in vitro senescence, BMSCs from 3 SLE
patients and 3 normal controls were monitored using the
SAb-gal assay, which is believed to be the most reliable
marker of senescence. The percent of SAb-gal-positive
BMSCs from SLE patients was 31.8%– 9.0%, significantly
higher than that of normal control BMSCs (12.4% – 0.7%)
(P < 0.05; Fig. 1B). However, no remarkable differences of
SAb-gal-positive cells were found in both P5 and P4 BMSCs
no matter SLE patients or normal controls. In addition, in-
creased proliferative index was shown in P5 and P4 normal
BMSCs, but it was similar in the same passage BMSCs of SLE
patients and normal controls (Supplementary Fig. S5).
Dysfunctional mitochondrial and DR pathway
in SLE BMSCs
To investigate the change of mitochondrial pathway
functions during apoptosis of SLE BMSCs, the mRNA ex-
pression of Bcl-2, Bcl-w, and Bax was measured by real-time
PCR. Results revealed that the antiapoptotic factor Bcl-2
mRNA expression was significantly decreased in SLE
BMSCs compared with normal controls, with or without
TNF-a stimulation (P < 0.05), while there were no significant
differences in mRNA expression of Bcl-w and Bax between
SLE patients and normal controls without TNF-a stimula-
tion. When BMSCs were treated with TNF-a for 48 h, the
mRNA expression of Bax of BMSCs significantly increased in
SLE patients compared with normal controls (Fig. 2A–C). We
also found that the percentage of Bcl-2-positive BMSCs, in-
vestigated by using FCM, was lower in SLE (11.0 – 9.1) than
in normal controls (56.2% – 18.5%, P < 0.05) (Fig. 2D). Cyto-
chrome C released from mitochondria into cytosol is another
mitochondrial event during apoptosis. Immunostaining was
performed to observe cytochrome C expression in the cyto-
solic fraction. The results showed that there were more
cytochrome-C-positive cells in SLE BMSCs compared with
normal controls (Fig. 2E).
We next sought to explore whether the DR pathway was
involved in apoptosis of BMSCs. In our study, the mRNA
levels of Fas, TNFR1, and caspase 8 were measured, and no
significant differences were seen between the 2 groups
without TNF-a stimulation. When cells were treated with
TNF-a for 48 h, the mRNA expression of Fas and caspase 8
significantly increased in SLE BMSCs compared with normal
controls (Fig. 3A–C). However, more activation of caspase 8
by FCM analysis was observed in SLE patients (Fig. 3D), and
the expression of Fas and TNFR1 was significantly higher in
SLE BMSCs compared with normal controls at the protein
level (Fig. 3E). Elevated serum levels of FasL and TNF-a
were also found, which reflected bone marrow microenvi-
ronment (Fig. 3F, G). BMSCs from SLE and normal controls
were treated with various concentrations of anti-Fas anti-
body (0, 5mg/mL, and 10 mg/mL), and the results showed
that apoptosis of BMSCs both in SLE and in normal controls
FIG. 3. The analysis of apoptosis-related DR pathway in SLE BMSCs. The mRNA expression of Fas, TNFR1, and caspase 8
was detected from 10 SLE patients and 10 normal controls, and data were shown as the mean ratio – SD of transcript levels
over GAPDH. No significant differences were seen in the 3 genes between the 2 groups without TNF-a stimulation. While
cells were treated with TNF-a for 48 h, the mRNA expression of Fas and caspase 8 was significantly increased in SLE BMSCs
(A–C). The percentage of activated caspase-8-positive SLE BMSCs (n = 8) elevated significantly compared with normal
controls (n = 8). (D) The expression of Fas and TNFR1 by western blot was significantly raised in SLE BMSCs compared with
normal controls (n = 3). (E) Higher levels of FasL and TNF-a in serum determined by ELISA were shown in SLE patients than
in normal controls (P < 0.05, n = 20) (F, G). (* means P< 0.05 compared with NC). TNFR1, tumor necrosis factor-a receptor 1;
ELISA, enzyme-linked immunosorbent assay.
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increased in the presence of anti-Fas antibody (5mg/mL and
10 mg/mL). However, no differences were found between
SLE and normal controls when BMSCs were stimulated by
anti-Fas antibody (Supplementary Fig. S6).
Upregulated intracellular ROS levels from SLE
BMSCs, which maybe associated with the
overexpression of p-FoxO3 and p-AKT
To quantify intracellular ROS production, DCF-stained
cells were analyzed by FCM. SLE BMSCs showed a right
shift compared with normal controls (Fig. 4A) (P < 0.05,
n = 5), suggesting that O2 - production might be higher in
SLE BMSCs.
To gain insight into the molecular characteristics par-
ticipating in the regulation of intracellular ROS levels of
SLE BMSCs, we measured the expression of PI3K, KRas,
and NRas at mRNA levels by real-time PCR. Results
showed that there were no differences between the 2 groups
(Fig. 4C–E). Then, we analyzed the expression of p-AKT
and p-FoxO3 of BMSCs from SLE patients and normal
controls by western blot analysis. As shown in Fig. 4B, p-
AKT and p-FoxO3 expression was upregulated (n = 4),
which might be a reflection of the abnormal expression of
intracellular ROS levels.
Discussion
Recently, SLE has been postulated by some to be a stem
cell disorder disease. A better understanding of the charac-
teristics of BMSC dysfunction in SLE could have major
clinical implications in SLE treatment. Our study demon-
strated that SLE BMSCs appear to show senescence in early
passages in tissue culture, in accordance with a previous
report [11]. In addition, there were more BMSCs undergoing
apoptosis in SLE patients than in normal controls. Thus, we
speculate that these 2 factors might be involved in functional
abnormalities in SLE BMSCs, in turn participating in the
pathogenesis of SLE.
To elucidate the signaling pathways related to BMSC
apoptosis, we analyzed 2 major apoptosis pathways: the
mitochondrial death pathway and the DR pathway. Accu-
mulating evidence suggests that apoptosis can be controlled
by the Bcl-2 family [21, 22]. Previous studies observed that
the apoptosis of BMSCs induced by H2O2 compromised
mitochondrial function, as evidenced by the release of cyto-
chrome C from mitochondria into cytosol [23]. Our results
show the involvement of an intrinsic pathway in SLE BMSC
apoptosis, including downregulation of Bcl-2 expression and
overexpression of cytochrome C in cytoplasm. These results
indicate that SLE BMSCs are prone to apoptosis involving a
mitochondrial death pathway. Multiple DRs and their
adapter can lead to cell apoptosis as well as other physio-
logical processes after cell injury in a caspase-8-independent
manner [24]. In this study, we did not detect any apparent
differences in Fas and TNFR1 mRNA expression between the
SLE patients and normal controls. However, Fas and TNFR1
expression was elevated in SLE BMSCs at the protein levels.
Elevated levels of FasL and TNF-a can partially reflect an
inflammatory bone marrow environment of SLE patients.
FIG. 4. The detection of intracellular ROS levels and its upstream regulated genes of BMSCs from SLE patients and normal
controls. Quantification of intracellular ROS levels was evaluated by DCF staining followed by FCM analysis. Result revealed
higher intracellular ROS levels in SLE patients than in normal controls (P < 0.05, n = 5) (A). Expression of PI3K, KRas, and
NRas from SLE patients had no disparity with normal controls at mRNA levels analyzed by real-time PCR (P > 0.05, n= 10)
(C–E). Increased expression of p-FoxO3 and p-AKT of SLE BMSCs was tested by western blot (B). GAPDH was used as
loading controls in real-time PCR and western blot (* means P < 0.05 compared with NC). ROS, reactive oxygen species; DCF,
2,7-dichlorofluorescein.
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Studies on BMSCs showed that H2O2-induced cell apoptosis
did not cause appreciable cleavage of caspase 8, indicating
that the extrinsic apoptosis pathway acts independently of
caspase 8 [23]. In our study, we indeed detected a change in
caspase 8 activity, although its expression remained similar
at the mRNA levels. Following TNF-a treatment, the
mRNA expression of caspase 8 and Bax was significantly
increased in SLE BMSCs compared with normal controls.
Our results suggest that this caspase is one of the molecules
through which TNFR1 initiates apoptotic signaling in
BMSC apoptosis. Together, these data confirm that apop-
tosis of SLE BMSCs occurs via a DR and a caspase-
dependent mechanism.
There are many factors related to senescence, including
irreversible DNA damage, ROS levels, and shortening of
telomeres [25]. Many investigations indicate that intracellular
ROS, such as super oxide anions and hydrogen peroxide,
mainly derived from the mitochondria, are intricately con-
nected to aging and survival [26]. PI3K/AKT has been rec-
ognized as an important signaling pathway that upregulates
intracellular ROS levels by stimulating oxidative metabolism
in the mitochondria [27]. AKT hyperactivation promotes
metabolic activity in the mitochondria and inhibits FoxO
transcriptional activity, resulting in highly increased ROS lev-
els. FoxO3 is essential for the regulation of HSC fate by
maintaining ROS below a harmful threshold [28, 29]. On the
other hand, loss of FoxO3 in the adult hematopoietic system
results in significantly increased levels of apoptosis in HSCs
[30]. In the present study, we observed an increased expression
of phosphorylation-FoxO3 (p-FoxO3) in SLE MSCs. The
phosphorylation of Fox3 impaired the activation of FoxO3,
resulting in cytoplasmic sequestration and inhibition of its
downstream transcriptional activity, which produced high
levels of ROS and caused senescence. Our results are consistent
with the observation that FoxO3 deficiency causes an increase
in neutrophil apoptosis in murine models of arthritis [31].
To further elucidate the mechanism underlying the ab-
normal expression of p-FoxO3 and ROS, we examined the
genes related to PI3K/AKT signaling pathway, including
KRas, Nras, PI3K, and AKT. The results showed that AKT
was highly expressed at the protein level, which is in line
with the forthcoming viewpoint that AKT was activated in
fibroblasts undergoing senescence [32]. Activated Ras leads
to growth arrest as a result of potent negative feedback that
abrogates PI3K signaling. On the other hand, it also can in-
duce DNA damage via the production of ROS [33]. Never-
theless, it is plausible to reason that there were no significant
augmentations of PI3K, KRas, and NRas at mRNA levels in
SLE patients in our study.
In conclusion, we provide strong evidence of increased
apoptosis in SLE BMSCs, as reflected by downregulation of
Bcl-2 and upregulation of cytochrome C in cytoplasm.
Apoptosis of BMSCs also led to the activation of caspase 8,
indicative of an activated extrinsic apoptosis pathway. Our
study also found that SLE BMSCs display an enhanced aging
process with overproduction of intracellular ROS, which
might be linked with upregulation of p-FoxO3 and its up-
stream gene AKT. All of these findings suggest that SLE
BMSCs are prone to senescence and apoptosis, which may
implicate the possible involvement of BMSCs in the patho-
genesis of SLE. Therefore, we speculate that allogenic but not
autologous MSCT might be preferable for SLE treatment.
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